Video

FUJIFILM Diosynth Biotechnologies Capacity Update June 2023: Cell & Gene

FUJIFILM Diosynth Biotechnologies (FDB) is a CDMO Partner for Life offering end-to-end development and manufacturing solutions. They combine 30 years’ experience and technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP facilities and superior program management to advance tomorrow’s medicines. Currently, FDB has over 4000 employees in 6 global locations.

Our presenters today include: Sarah Maxfield, Global Vice President, Commercial Development and Melissa Quick, Global Vice President, Enterprise Business Planning. They’ll present a high level overview of FDB’s capabilities, discuss their global facilities network, and provide capacity updates for Advanced Therapy products.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

FUJIFILM Diosynth Biotechnologies